First Time Loading...

AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 5.83 USD 2.82% Market Closed
Updated: May 8, 2024

Gross Margin
AxoGen Inc

78.3%
Current
80%
Average
47%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.3%
=
Gross Profit
128.3m
/
Revenue
163.7m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
US
AxoGen Inc
NASDAQ:AXGN
254.7m USD
78%
US
Abbott Laboratories
NYSE:ABT
184.7B USD
55%
US
Intuitive Surgical Inc
NASDAQ:ISRG
137.9B USD
66%
US
Stryker Corp
NYSE:SYK
126.5B USD
64%
IE
Medtronic PLC
NYSE:MDT
108.9B USD
66%
US
Boston Scientific Corp
NYSE:BSX
107.9B USD
69%
US
Becton Dickinson and Co
NYSE:BDX
68.5B USD
41%
DE
Siemens Healthineers AG
XETRA:SHL
58B EUR
36%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
370.8B CNY
65%
US
Edwards Lifesciences Corp
NYSE:EW
51.7B USD
77%
US
Dexcom Inc
NASDAQ:DXCM
51.5B USD
63%
AxoGen Inc
NASDAQ:AXGN
Country US
Market Cap 254.7m USD
Gross Margin
78%
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 184.7B USD
Gross Margin
55%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 137.9B USD
Gross Margin
66%
Stryker Corp
NYSE:SYK
Country US
Market Cap 126.5B USD
Gross Margin
64%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 108.9B USD
Gross Margin
66%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 107.9B USD
Gross Margin
69%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 68.5B USD
Gross Margin
41%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 58B EUR
Gross Margin
36%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 370.8B CNY
Gross Margin
65%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 51.7B USD
Gross Margin
77%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 51.5B USD
Gross Margin
63%

Profitability Report

View the profitability report to see the full profitability analysis for AxoGen Inc.

Full Profitability Report

See Also

Summary
AXGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AXGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AXGN stock valuation using valuation multiples.
Wall Street Estimates
AXGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AXGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.3%
=
Gross Profit
128.3m
/
Revenue
163.7m
What is the Gross Margin of AxoGen Inc?

Based on AxoGen Inc's most recent financial statements, the company has Gross Margin of 78.3%.

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.